FDA Inspection 1223219 — Biomet, Inc.

Biomet, Inc. — FEI 1825034

The FDA completed an inspection of Biomet, Inc. on November 9, 2023 in Warsaw, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 9, 2023
Fiscal Year
2024
Product Type
Devices
Project Area
Compliance: Devices
Location
Warsaw, IN (United States)